Trials / Completed
CompletedNCT01723618
Pharmacokinetics of CRD007 in Patients With Abdominal Aorta Aneurisms.
An Open-label, Randomised, Uncontrolled Trial Investigating the Pharmacokinetics of CRD007 After Single Dose Administration to Subjects With Abdominal Aortic Aneurysm (AAA)
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 18 (actual)
- Sponsor
- RSPR Pharma AB · Industry
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to determine the plasma levels of CRD007 in patients with abdominal aortic aneurysms after the administration of single doses of tablets containing 10, 25 and 40 mg CRD007.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | CRD007 |
Timeline
- Start date
- 2012-11-01
- Primary completion
- 2012-11-01
- Completion
- 2012-11-01
- First posted
- 2012-11-08
- Last updated
- 2012-11-29
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT01723618. Inclusion in this directory is not an endorsement.